Literature DB >> 16098152

Opinions of women with high inherited breast cancer risk about prophylactic mastectomy: an initial evaluation from a screening trial including magnetic resonance imaging and ductal lavage.

Allison W Kurian1, Anne-Renee Hartman, Meredith A Mills, James M Ford, Bruce L Daniel, Sylvia K Plevritis.   

Abstract

OBJECTIVE: Prophylactic mastectomy (PM) is often considered, but variably chosen by women at high inherited risk of breast cancer; few data exist on patient tolerance of intensive breast screening as an alternative to PM. We performed an evaluation of high-risk women's tolerance of a breast screening protocol using clinical breast examination, mammography, breast magnetic resonance imaging (MRI) and ductal lavage (DL), and of change in attitudes toward PM after screening.
DESIGN: A questionnaire assessing tolerance of screening procedures and change in opinion towards PM was designed and administered to 43 study participants, after a median follow-up of 13 months. Responses were evaluated according to patient characteristics, including type of study-prompted interventions, BRCA mutation status, and prior history of cancer, via univariate analysis.
RESULTS: Most patients [85.3% (68.9-95.1%)] were more opposed or unchanged in their attitudes towards PM after study participation, with only 14.7% (5.0-31.1%) less opposed (P = 0.017) despite a short-interval follow-up MRI rate of 71.7% and a biopsy rate of 37%. Lower rates of maximal discomfort were reported with mammogram [2.8% (0-14.5%)] and MRI [5.6% (0-18.7%)] than with DL [28.6% (14.6-46.3%)], with P = 0.035.
CONCLUSIONS: Most high-risk women tolerated intensive breast screening well; they were not more inclined towards PM after participating. Future studies should prospectively evaluate larger numbers of high-risk women via multivariate analysis, to determine characteristics associated with preference for breast screening vs. PM.

Entities:  

Mesh:

Year:  2005        PMID: 16098152      PMCID: PMC5060291          DOI: 10.1111/j.1369-7625.2005.00333.x

Source DB:  PubMed          Journal:  Health Expect        ISSN: 1369-6513            Impact factor:   3.377


  53 in total

1.  Intensity-modulated parametric mapping for simultaneous display of rapid dynamic and high-spatial-resolution breast MR imaging data.

Authors:  A T Agoston; B L Daniel; R J Herfkens; D M Ikeda; R L Birdwell; S G Heiss; A M Sawyer-Glover
Journal:  Radiographics       Date:  2001 Jan-Feb       Impact factor: 5.333

2.  False-negative MR imaging of malignant breast tumors.

Authors:  C Boetes; S P Strijk; R Holland; J O Barentsz; R F Van Der Sluis; J H Ruijs
Journal:  Eur Radiol       Date:  1997       Impact factor: 5.315

Review 3.  High-resolution MR imaging of the breast.

Authors:  S G Orel
Journal:  Semin Ultrasound CT MR       Date:  1996-10       Impact factor: 1.875

4.  MR imaging of the breast: technical approach and clinical experience.

Authors:  S E Harms; D P Flamig
Journal:  Radiographics       Date:  1993-07       Impact factor: 5.333

5.  Risk-reducing salpingo-oophorectomy in women with a BRCA1 or BRCA2 mutation.

Authors:  Noah D Kauff; Jaya M Satagopan; Mark E Robson; Lauren Scheuer; Martee Hensley; Clifford A Hudis; Nathan A Ellis; Jeff Boyd; Patrick I Borgen; Richard R Barakat; Larry Norton; Mercedes Castiel; Khedoudja Nafa; Kenneth Offit
Journal:  N Engl J Med       Date:  2002-05-20       Impact factor: 91.245

6.  Long-term psychological impact of carrying a BRCA1/2 mutation and prophylactic surgery: a 5-year follow-up study.

Authors:  Iris van Oostrom; Hanne Meijers-Heijboer; Litanja N Lodder; Hugo J Duivenvoorden; Arthur R van Gool; Caroline Seynaeve; Conny A van der Meer; Jan G M Klijn; Bert N van Geel; Curt W Burger; Juriy W Wladimiroff; Aad Tibben
Journal:  J Clin Oncol       Date:  2003-10-15       Impact factor: 44.544

7.  MRI of occult breast carcinoma in a high-risk population.

Authors:  Elizabeth A Morris; Laura Liberman; Douglas J Ballon; Mark Robson; Andrea F Abramson; Alexandra Heerdt; D David Dershaw
Journal:  AJR Am J Roentgenol       Date:  2003-09       Impact factor: 3.959

8.  The calculation of breast cancer risk for women with a first degree family history of ovarian cancer.

Authors:  E B Claus; N Risch; W D Thompson
Journal:  Breast Cancer Res Treat       Date:  1993-11       Impact factor: 4.872

9.  Contralateral breast cancer in BRCA1 and BRCA2 mutation carriers.

Authors:  Kelly Metcalfe; Henry T Lynch; Parviz Ghadirian; Nadine Tung; Ivo Olivotto; Ellen Warner; Olufunmilayo I Olopade; Andrea Eisen; Barbara Weber; Jane McLennan; Ping Sun; William D Foulkes; Steven A Narod
Journal:  J Clin Oncol       Date:  2004-06-15       Impact factor: 44.544

10.  A BRCA1/2 mutation, high breast density and prominent pushing margins of a tumor independently contribute to a frequent false-negative mammography.

Authors:  Madeleine Tilanus-Linthorst; Leon Verhoog; Inge-Marie Obdeijn; Karina Bartels; Marian Menke-Pluymers; Alexander Eggermont; Jan Klijn; Hanne Meijers-Heijboer; Theo van der Kwast; Cecile Brekelmans
Journal:  Int J Cancer       Date:  2002-11-01       Impact factor: 7.396

View more
  5 in total

1.  Survival analysis of cancer risk reduction strategies for BRCA1/2 mutation carriers.

Authors:  Allison W Kurian; Bronislava M Sigal; Sylvia K Plevritis
Journal:  J Clin Oncol       Date:  2009-12-07       Impact factor: 44.544

2.  Perception of screening and risk reduction surgeries in patients tested for a BRCA deleterious mutation.

Authors:  Jennifer K Litton; Shannon N Westin; Kaylene Ready; Charlotte C Sun; Susan K Peterson; Funda Meric-Bernstam; Ana M Gonzalez-Angulo; Diane C Bodurka; Karen H Lu; Gabriel N Hortobagyi; Banu K Arun
Journal:  Cancer       Date:  2009-04-15       Impact factor: 6.860

3.  Cancer risk reduction and reproductive concerns in female BRCA1/2 mutation carriers.

Authors:  Ashley D Staton; Allison W Kurian; Kristin Cobb; Meredith A Mills; James M Ford
Journal:  Fam Cancer       Date:  2007-11-17       Impact factor: 2.375

Review 4.  Risk-reducing mastectomy for the prevention of primary breast cancer.

Authors:  Nora E Carbine; Liz Lostumbo; Judi Wallace; Henry Ko
Journal:  Cochrane Database Syst Rev       Date:  2018-04-05

5.  Tolerability of breast ductal lavage in women from families at high genetic risk of breast cancer.

Authors:  Jennifer T Loud; Ellen Burke Beckjord; Kathryn Nichols; June Peters; Ruthann Giusti; Mark H Greene
Journal:  BMC Womens Health       Date:  2009-07-14       Impact factor: 2.809

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.